(Q42970799)

English

Impact of prior invasive aspergillosis on outcome in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplant

scientific article published on September 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 November 2017

Impact of prior invasive aspergillosis on outcome in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplant (English)

1 reference

Europe PubMed Central

12 November 2017

0 references

invasive aspergillosis

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

12 November 2017

9

object named as

Didier Blaise

1 reference

Europe PubMed Central

12 November 2017

author name string

Jean El-Cheikh

1

1 reference

Europe PubMed Central

12 November 2017

Ling Wang

3

1 reference

Europe PubMed Central

12 November 2017

Benjamin Esterni

4

1 reference

Europe PubMed Central

12 November 2017

Catherine Faucher

5

1 reference

Europe PubMed Central

12 November 2017

Sabine Fürst

6

1 reference

Europe PubMed Central

12 November 2017

Berger Pierre

7

1 reference

Europe PubMed Central

12 November 2017

Mohamad Mohty

8

1 reference

Europe PubMed Central

12 November 2017

publication date

1 September 2010

1 reference

Europe PubMed Central

12 November 2017

Leukemia & Lymphoma

1 reference

Europe PubMed Central

12 November 2017

51

1 reference

Europe PubMed Central

12 November 2017

9

1 reference

Europe PubMed Central

12 November 2017

1705-1710

1 reference

Europe PubMed Central

12 November 2017

Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500433

21 January 2018

Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: A retrospective survey of the Infectious Diseases Working Party of th

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500433

21 January 2018

Infections in non-myeloablative hematopoietic stem cell transplantation patients with lymphoid malignancies: spectrum of infections, predictors of outcome and proposed guidelines for fungal infection prevention

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500433

21 January 2018

Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500433

21 January 2018

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500433

21 January 2018

Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin-based reduced-intensity preparative regimen

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500433

21 January 2018

Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500433

21 January 2018

Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500433

21 January 2018

Invasive mold infections in allogeneic bone marrow transplant recipients.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500433

21 January 2018

Impact of previous aspergillosis on the outcome of bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500433

21 January 2018

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500433

21 January 2018

Combination antifungal therapy for invasive aspergillosis

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500433

21 January 2018

Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500433

21 January 2018

Secondary antifungal prophylaxis with voriconazole to adhere to scheduled treatment in leukemic patients and stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500433

21 January 2018

Efficacy of caspofungin as secondary prophylaxis in patients undergoing allogeneic stem cell transplantation with prior pulmonary and/or systemic fungal infection

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500433

21 January 2018

Haemopoietic cell transplantation of patients with a history of deep or invasive fungal infection during prophylaxis with liposomal amphotericin B.

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500433

21 January 2018

Clinical issues regarding relapsing aspergillosis and the efficacy of secondary antifungal prophylaxis in patients with hematological malignancies

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500433

21 January 2018

Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimen

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500433

21 January 2018

Differences in patterns of infection and inflammation for corticosteroid treatment and chemotherapy in experimental invasive pulmonary aspergillosis

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500433

21 January 2018

Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500433

21 January 2018

Invasive aspergillosis before allogeneic hematopoietic stem cell transplantation: 10-year experience at a single transplant center

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.500433

21 January 2018

Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1086/422009

Identifiers

10.3109/10428194.2010.500433

1 reference

Europe PubMed Central

12 November 2017

1 reference

Europe PubMed Central

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42970799&oldid=1975545174"